May 02, 2012, 07.05 PM | Source: CNBC-TV18
D D Sharma of Risk Capital Advisors is of the view that one should buy Biocon.
Sharma told CNBC-Awaaz, "One can accumulate Biocon with a stoploss of Rs 229. The stock can touch level of Rs 255 in medium term."
The company touched its 52-week high Rs 382.00 and 52-week low Rs 225.75 on 20 Jul, 2011 and 27 Apr, 2012, respectively.
Currently, it is trading -37.72% below its 52-week high and 5.38% above its 52-week low.
Rahul Shah of Motilal Oswal is of the view that on
Ashwani Gujral of ashwanigujral.com is of the view
Jay Thakkar of Sharekhan is of the view that one m
Sudarshan Sukhani of s2analytics.com likes Biocon
Amit Gupta of ICICIdirect is of the view that one
Here are a few top buzzing midcap stocks picked up
Watch the interview of Renisha Chainani of Edelwei
Ashwani Gujral of ashwanigujral.com recommends buy